227 related articles for article (PubMed ID: 22975528)
1. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
2. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma.
Deng X; Liu P; Zhao Y; Wang Q
Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
5. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
6. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
7. CEACAM6 gene expression in intrahepatic cholangiocarcinoma.
Ieta K; Tanaka F; Utsunomiya T; Kuwano H; Mori M
Br J Cancer; 2006 Aug; 95(4):532-40. PubMed ID: 16868542
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
9. CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer.
Zhang Y; Zang M; Li J; Ji J; Zhang J; Liu X; Qu Y; Su L; Li C; Yu Y; Zhu Z; Liu B; Yan M
Acta Biochim Biophys Sin (Shanghai); 2014 Apr; 46(4):283-90. PubMed ID: 24492534
[TBL] [Abstract][Full Text] [Related]
10. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen.
Maraqa L; Cummings M; Peter MB; Shaaban AM; Horgan K; Hanby AM; Speirs V
Clin Cancer Res; 2008 Jan; 14(2):405-11. PubMed ID: 18223215
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
Tsang JY; Kwok YK; Chan KW; Ni YB; Chow WN; Lau KF; Shao MM; Chan SK; Tan PH; Tse GM
Breast Cancer Res Treat; 2013 Nov; 142(2):311-22. PubMed ID: 24186057
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM
BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
Litkouhi B; Litkouhi B; Fleming E; Welch WR; Berkowitz RS; Birrer MJ; Mok SC
Gynecol Oncol; 2008 May; 109(2):234-9. PubMed ID: 18331757
[TBL] [Abstract][Full Text] [Related]
15. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.
Schölzel S; Zimmermann W; Schwarzkopf G; Grunert F; Rogaczewski B; Thompson J
Am J Pathol; 2000 Feb; 156(2):595-605. PubMed ID: 10666389
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.
Douard R; Le Maire V; Wind P; Sales JP; Dumas F; Fayemendi L; Landi B; Benichou J; Cugnenc PH; Gayral F; Loric S
Surgery; 2001 May; 129(5):587-94. PubMed ID: 11331451
[TBL] [Abstract][Full Text] [Related]
18. Expression of carcinoembryonic antigen cell adhesion molecule 6 oncoprotein in atypical ductal hyperplastic tissues is associated with the development of invasive breast cancer.
Poola I; Shokrani B; Bhatnagar R; DeWitty RL; Yue Q; Bonney G
Clin Cancer Res; 2006 Aug; 12(15):4773-83. PubMed ID: 16899629
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: In vivo effects of vaccine containing 4-1BBL and CEACAM6.
Jin C; Liu Y; Zhu J; Xia T; Zhang B; Fei Y; Ma B; Ye J; Chen W
Oncol Rep; 2015 Jun; 33(6):2837-44. PubMed ID: 25872647
[TBL] [Abstract][Full Text] [Related]
20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
